Why Patients Come Back Within 30 Days

The gap between hospital discharge and home. What it costs when patients aren't ready for it.

A patient spends a week in the hospital. They receive their medication on time, every time. Because the nursing team handles it. On the day they leave, a box of tablets is handed to them at the door, and by the time they get home, they've forgotten which one to take first, what time to take it, and whether the two small white ones are the same or different.

Within 30 days, they're back.

This isn't a rare edge case. The evidence has been clear on this for years.

Studies show that approximately 20% of hospital readmissions are medication-related. Up to 70% of those are considered potentially preventable.

That figure sits at the heart of a much bigger problem the NHS is actively working to address. The NHS 10 Year Plan sets a clear direction: move care closer to home, reduce unnecessary hospital admissions, and build a health service that prepares patients, not just treats them. Readmissions driven by medication non-adherence sit exactly where the NHS needs to make progress.

What actually goes wrong after discharge?

It's not usually a prescribing error. The problem is simpler and harder to fix: the patient doesn't understand their regimen well enough to manage it alone once the support disappears.

Research published in Frontiers in Pharmacology found that of preventable medication-related readmissions, 35% were caused by prescribing errors, 35% by non-adherence, and 30% by transition errors. In other words, failures in communicating the medication plan at the point of discharge. That's two-thirds of preventable readmissions tied directly to knowledge gaps and communication breakdowns, not to clinical mistakes.

A separate UK multicentre study estimated the NHS cost of post-discharge medication harm in older adults at around £396 million annually, with over 90% of that attributable to hospital readmissions. Almost one in three older adults was found to be non-adherent in the weeks after leaving the hospital.

The de-skilling problem

There's a specific dynamic at play during hospital stays that doesn't get talked about enough. When a patient is admitted, the nursing team takes over their medication. That's the right thing to do clinically. But it means the patient, who may have been managing their own tablets perfectly well at home for years, spends days or weeks not doing it themselves.

By the time they're discharged, the routine is gone. The confidence has dropped. And the instructions on a discharge sheet, however clear, don't fully replace the habit.

This is what self-administration of medication (SAM) is designed to address. Not as a policy tick-box, but as a clinical approach that keeps patients practising, learning, and preparing while they're still in a supported environment.

SAM isn't new. The gap is in governance.

Self-administration programmes have been part of NHS guidance for some time. The evidence for their value in improving medication knowledge, adherence, and patient confidence is established. The challenge has always been the operational side: how do you run a safe, auditable SAM programme at ward level without adding to an already stretched nursing team?

That's where the governance question comes in. If a patient is managing their own medication in a bedside drawer with a paper tick chart, there's no reliable audit trail. The nurse has to manually retrieve the chart, review it, and enter the data. It's slow, it's inconsistent, and it doesn't give pharmacy or clinical leads the visibility they need.

Technology doesn't change the clinical decision to allow SAM. That remains with the clinical team. What it changes is the infrastructure around that decision: the logging, the prompting, the secure access, and the data that flows back to the patient record.

Person-centred pharmaceutical care and medicines support during the inpatient stay, including education and risk management, may reduce the likelihood of 30-day readmission by up to 40%.

That finding, from a UK-based NHS study published in peer-reviewed literature, points to something straightforward: the work that reduces readmissions happens before discharge, not after it.

What the NHS 10 Year Plan says about this

The NHS 10 Year Plan is explicit about the need to shift from hospital care to community care, and to reduce avoidable hospital admissions. Medication non-adherence sits squarely in the path of that ambition.

NHS England's medication safety management framework makes clear that patients should be fully informed about the medicines they're being prescribed. Not just at the point of dispensing, but throughout their care. Time-critical medicines, omitted doses, nd transition errors are all active areas of focus within the national Medicines Safety Improvement Programme.

The point isn't to assign blame. It's to recognise where the system currently drops the patient, and where better preparation, supported by the right tools, can close that gap.

Where Med-Side fits

Med-Side is designed to support SAM at the bedside. It holds a patient's medication securely, prompts them when a dose is due, guides them through the right drug and dose via the screen, and logs the interaction directly to the patient's EPR record in real time.

It's not replacing the pharmacist's role. It's not bypassing clinical assessment of whether SAM is appropriate for a given patient. What it does is give clinical teams a structured, governed way to run SAM. One that comes with an audit trail that satisfies clinical governance requirements, and data that nursing and pharmacy teams can actually use.

The patient who leaves the hospital having spent their last few days managing their own medication, with reminders, the right information on screen, and every interaction recorded, is a different patient to the one who walks out with a box of tablets and a leaflet.

That difference is what sits between a good discharge and a 30-day readmission.

‍

This blog draws on peer-reviewed research, including Frontiers in Pharmacology (El Morabet et al., 2021), PLOS ONE (2021), PMC person-centred pharmaceutical care (Newcastle NHS, 2016), and NHS England's 10 Year Health Plan and Medication Safety Management guidance. All claims are referenced to published sources.

Want to see how Med-Side supports SAM in practice?

Book a demo with the Kinetic-ID team.

Book a demo

‍